Rhythm Pharmaceuticals, Inc. (RYTM)

Rhythm Pharmaceuticals Revenue

Rhythm Pharmaceuticals had revenue of $48.50M in the quarter ending June 30, 2025, with 66.80% growth. This brings the company's revenue in the last twelve months to $156.29M, up 53.55% year-over-year. In the year 2024, Rhythm Pharmaceuticals had annual revenue of $130.13M with 68.06% growth.

• Revenue (ttm): $156.29M
• Revenue Growth: +53.55%
• P/S Ratio: 39.85
• Revenue / Employee: $552,251
• Employees: 283
• Market Cap: 6.64B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	130.13M	52.70M	68.06%
Dec 31, 2023	77.43M	53.79M	227.56%
Dec 31, 2022	23.64M	20.48M	649.46%
Dec 31, 2021	3.15M	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.